← All diseases
Cancer
Liver cancer
Do you want to receive a message when there is new research about Liver cancer? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, one sentence above each publication explains what was studied — and you'll be notified as soon as new research on Liver cancer is available. View what Premium costs.
Publications and studies (3377)
- Disease-Associated Risk Variants and Expression Levels of the lncRNA, CDKN2B-AS1, Are Associated With the Progression of HCC. (2025/03/01) ♡
- Plasma Extracellular Vesicle-derived MicroRNA Associated with Human Alpha-1 Antitrypsin Deficiency-mediated Liver Disease. (2025/02/28) ♡
- Development and validation of a basement membrane-associated immune prognostic model for hepatocellular carcinoma. (2025/02/23) ♡
- Mitochondrial damage and associated combined toxicity induced by deoxynivalenol and Alternaria toxins co-exposure. (2025/02/15) ♡
- DSN1 Interaction With Centromere-Associated Proteins Promotes Chromosomal Instability in Hepatocellular Carcinoma. (2025/02/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Dietary inflammatory potential and metabolic (dysfunction) -associated steatotic liver disease and its complications: A comprehensive review. (2025/02/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Management of Chronic Liver Disease in Patients with Hepatocellular Carcinoma. (2025/02/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The Role of Palliative Care in the Management of Patients with Hepatocellular Carcinoma. (2025/02/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Trajectories of postoperative hepatitis B virus (HBV) DNA and HBV-related hepatocellular carcinoma outcomes. (2025/02/01) ♡
- Access to Evaluation for Liver Transplantation in the Veterans Health Administration. (2025/02/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Metabolic dysfunction-associated steatotic liver disease: heterogeneous pathomechanisms and effectiveness of metabolism-based treatment. (2025/02/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Neoadjuvant immunotherapy for hepatocellular carcinoma: progress and perspectives. (2025/02/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Drug delivery systems based on mesoporous silica nanoparticles for the management of hepatic diseases. (2025/02/01) ♡
- Unlocking the potential of Traditional Chinese Medicine (TCM): Shipi Xiaoji formula (SPXJF) as a novel ferroptosis inducer in hepatocellular carcinoma. (2025/01/31) ♡
- Mechanism of Shashen-Maidong herb pair in treating hepatocellular carcinoma using network pharmacology and experimental validation. (2025/01/30) ♡
- [Biejiajian Pill Regulates Ferroptosis in Hepatocellular Carcinoma Cells via P62/Keap1/Nrf2 Signaling Pathway: A Mechanism Study]. (2025/01/20) ♡
- Liver sinusoidal endothelial cells regulate the balance between hepatic immunosuppression and immunosurveillance. (2025/01/17) ♡
- Exploring the potential of some natural indoles as antiviral agents: quantum chemical analysis, inverse molecular docking, and affinity calculations. (2025/01/16) ♡
- TMP: A dual modulator of apoptosis and autophagy via SHP-1 regulation in hepatocellular carcinoma. (2025/01/15) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The effect of folate deficiency and different doses of folic acid supplementation on liver diseases. (2025/01/14) ♡
- Xiaoai Jiedu recipe reduces cell survival and induces apoptosis in hepatocellular carcinoma by stimulating autophagy via the Akt/mTOR pathway. (2025/01/13) ♡
- A Notch signaling pathway-related gene signature: Characterizing the immune microenvironment and predicting prognosis in hepatocellular carcinoma. (2025/01/10) ♡
- Berberine in combination with anti-PD-L1 suppresses hepatocellular carcinoma progression and metastasis via Erk signaling pathway. (2025/01/09) ♡
- HDAC inhibition by Nigella sativa L. sprouts extract in hepatocellular carcinoma: an approach to study anti-cancer potential. (2025/01/01) ♡
- A genetic basis of mitochondrial DNAJA3 in nonalcoholic steatohepatitis-related hepatocellular carcinoma. (2025/01/01) ♡
- ALDOB/KAT2A interactions epigenetically modulate TGF-β expression and T cell functions in hepatocellular carcinogenesis. (2025/01/01) ♡
- Revealing the active ingredients and mechanisms of Xiatianwu against hepatocellular carcinoma: a study based on network pharmacology and bioinformatics. (2025/01/01) ♡
- Autocrine and paracrine LIF signals to collaborate sorafenib resistance in hepatocellular carcinoma and effects of Kanglaite Injection. (2025/01/01) ♡
- Crucial Role of C-MYC/Monocarboxylate Transporter 4 Signaling in Capsaicin Induced Apoptotic and Anti-Warburg Effects in Hepatocellular Carcinoma. (2025/01/01) ♡
- Investigating the Mechanism of Hedysarum Multijugum Maxim in the Treatment of Liver Cancer through Network Pharmacology and Molecular Docking Validation. (2025/01/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. How the liver transcriptome and lipid composition influence the progression of nonalcoholic fatty liver disease to hepatocellular carcinoma in a murine model. (2025/01/01) ♡
- Short-term exposure to low doses of aflatoxin B1 aggravates nonalcoholic steatohepatitis by TLR4-mediated necroptosis. (2025/01/01) ♡
- Alternative splicing is an FXRα loss-of-function mechanism and impacts energy metabolism in hepatocarcinoma cells. (2025/01/01) ♡
- Free fatty acid-induced DDX3 inhibits autophagy via miR-141 upregulation in diet-induced MASLD mice model system. (2025/01/01) ♡
- Association between the dietary inflammatory index and the risk of hepatocellular carcinoma in a cirrhotic population. (2025/01/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Chronic inorganic nitrate supplementation does not improve metabolic health and worsens disease progression in mice with diet-induced obesity. (2025/01/01) ♡
- Unlocking Therapeutic Potential: Camphorquinone's Role in Alleviating Non-Alcoholic Fatty Liver Disease via SIRT1/LKB1/AMPK Pathway Activation. (2025/01/01) ♡
- CDT1 is a Potential Therapeutic Target for the Progression of NAFLD to HCC and the Exacerbation of Cancer. (2025/01/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Effect of Crocus sativus L. (saffron) and Rosmarinus officinalis L. (rosemary) in hepatocellular carcinoma: A narrative review of current evidence and prospects. (2025/01/01) ♡
- Pro-Apoptosis Effects of Yangzheng-Xiaoji Capsules in Hepatocellular Carcinoma: Activation of the P53-Induced Apoptotic Pathway and Inhibition of the PI3K/Akt Pathway. (2025/01/01) ♡
- Anti-Hepatocellular Carcinoma Effect of Jianpi Huayu Formula: Revealing the Molecular Mechanisms of the CXCR4 - Smad2/3 Pathway in Regulating Vasculogenic Mimicry Formation and Epithelial-Mesenchymal Transition. (2025/01/01) ♡
- Mechanism of Jiedu Prescription in Hepatocellular Carcinoma: Integrating Network Pharmacology and Experimental Validation. (2025/01/01) ♡
- Advances in the understanding of health disparities in the United States Hispanic population. (2025/01/01) ♡
- Prognostic value of the neutrophil-to-lymphocyte ratio and prognostic nutritional index in unresectable hepatocellular carcinoma patients treated with tyrosine kinase inhibitors and immune checkpoint inhibitors. (2024/12/31) ♡
- Dnajb1-pkac Kinase Is Expressed in Young Patients with Pediatric Liver Cancers and Enhances Carcinogenic Pathways. (2024/12/30) ♡
- Cell Therapy Using Anti-NKG2a Pretreated Natural Killer Cells in Patients with Hepatocellular Carcinoma. (2024/12/30) ♡
- A metal-drug self-delivery nanomedicine alleviates tumor immunosuppression to potentiate synergistic chemo/chemodynamic therapy against hepatocellular carcinoma. (2024/12/30) ♡
- Yu-Ping-Feng-San improves the immunosuppression of the microenvironment in hepatocellular carcinoma by promoting the maturation of DCs through the JAK2-STAT3 pathway. (2024/12/28) ♡
- High Frequency of CTNNB1 Variants Associated with Benign and Malignant Liver Tumors in Patients with Congenital Porto-Systemic Shunts. (2024/12/28) ♡
- Hypoxia upregulates hepatic angiopoietin-2 transcription to promote the progression of hepatocellular carcinoma. (2024/12/27) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.